MiSight® 1 day news

Articles:

More from CooperVision

CooperVision

November 16, 2020

One Year After FDA Approval, MiSight® 1 Day Contact Lens Mainstreams Myopia Management in the U.S.

Read Press Release

CooperVision

October 9, 2020

CooperVision Presents Six-Year Data from MiSight® 1 Day Study; 23% of Eyes Showed No Additional Myopia Progression After Fitting

Read Press Release

CooperVision

November 18, 2019

Breakthrough CooperVision MiSight® 1 Day Contact Lens for Childhood Myopia Coming to the United States in 2020

Read Press Release

MiSight® 1 day FDA approval

FDA approves MiSight® 1 day so contact lens specifically designed to slow the progression of nearsightedness in children aged 8-12 at the initiation of treatment^1†
Read Article

MiSight® 1 day 6-year clinical trial results
Read Article

MiSight® 1 day 3-year clinical trial results
Read Article

Product specifications
Download PDF

Patient information booklet
Download PDF